OraSure Technologies (OSUR) Stock Forecast, Price & News

0 equities research analysts have issued 12 month price targets for OraSure Technologies' shares. Their OSUR share price forecasts range from $5.00 to $5.00. On average, they anticipate the company's stock price to reach $5.00 in the next twelve months. This suggests that the stock has a possible downside of 9.6%.
View analysts price targets for OSUR or view top-rated stocks among Wall Street analysts.

OraSure Technologies' stock was trading at $4.82 at the start of the year. Since then, OSUR shares have increased by 14.7% and is now trading at $5.53.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our OSUR earnings forecast.

OraSure Technologies, Inc. (NASDAQ:OSUR) posted its earnings results on Tuesday, February, 14th. The medical instruments supplier reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.21. The medical instruments supplier earned $123.08 million during the quarter, compared to the consensus estimate of $96.88 million. OraSure Technologies had a net margin of 6.16% and a trailing twelve-month return on equity of 12.66%. OraSure Technologies's quarterly revenue was up 93.6% on a year-over-year basis. During the same period in the prior year, the company posted ($0.14) EPS.

ETFs with the largest weight of OraSure Technologies (NASDAQ:OSUR) stock in their portfolio include Inspire Fidelis Multi Factor ETF (FDLS), ETFMG Treatments Testing and Advancements ETF (GERM), Invesco Nasdaq Future Gen 200 ETF (QQQS), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), Syntax Stratified SmallCap ETF (SSLY), Principal Healthcare Innovators ETF (BTEC) and

OraSure Technologies issued an update on its second quarter 2023 earnings guidance on Friday, May, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $62.00 million-$67.00 million, compared to the consensus revenue estimate of $96.67 million.

2 employees have rated OraSure Technologies Chief Executive Officer Stephen Tang on Glassdoor.com. Stephen Tang has an approval rating of 100% among the company's employees. This puts Stephen Tang in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), Energy Transfer (ET), XOMA (XOMA), Overstock.com (OSTK), Ford Motor (F), Pfizer (PFE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

OraSure Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (17.62%), State Street Corp (4.11%), Dimensional Fund Advisors LP (3.64%), American Capital Management Inc. (3.03%), Renaissance Technologies LLC (2.07%) and Geode Capital Management LLC (1.92%). Insiders that own company stock include Michael Celano, Nancy J Gagliano and Ronny B Lancaster.
View institutional ownership trends.

Shares of OSUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OSUR stock can currently be purchased for approximately $5.53.

OraSure Technologies (NASDAQ:OSUR) has a market capitalization of $405.13 million and generates $387.48 million in revenue each year. The medical instruments supplier earns $-17,930,000.00 in net income (profit) each year or $0.39 on an earnings per share basis.

The company employs 785 workers across the globe.

OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The official website for the company is www.orasure.com. The medical instruments supplier can be reached via phone at (610) 882-1820, via email at investorinfo@orasure.com, or via fax at 610-882-1830.